Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate
CompletedOBSERVATIONAL
Enrollment
90
Participants
Timeline
Start Date
July 31, 2015
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Conditions
Schizophrenia
Trial Locations (7)
Unknown
Rijeka
Split
Zagreb
Moscow
Saint Petersburg
Ankara
Denizli
All Listed Sponsors
lead
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
NCT02532842 - Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate | Biotech Hunter | Biotech Hunter